21.11
0.18 (0.86%)
| Previous Close | 20.93 |
| Open | 21.07 |
| Volume | 1,560,772 |
| Avg. Volume (3M) | 1,470,096 |
| Market Cap | 2,706,500,608 |
| Price / Earnings (Forward) | 21.88 |
| Price / Sales | 0.830 |
| Price / Book | 1.55 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Profit Margin | -6.09% |
| Operating Margin (TTM) | 11.55% |
| Diluted EPS (TTM) | -1.53 |
| Quarterly Revenue Growth (YOY) | 8.20% |
| Total Debt/Equity (MRQ) | 108.05% |
| Current Ratio (MRQ) | 1.89 |
| Operating Cash Flow (TTM) | 265.40 M |
| Levered Free Cash Flow (TTM) | 142.56 M |
| Return on Assets (TTM) | 3.97% |
| Return on Equity (TTM) | -0.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Surgery Partners, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -4.0 |
| Average | -0.25 |
|
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 1.51% |
| % Held by Institutions | 111.91% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Glenview Capital Management, Llc | 30 Jun 2025 | 1,529,225 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 36.00 (Cantor Fitzgerald, 70.54%) | Buy |
| Median | 31.50 (49.22%) | |
| Low | 27.00 (JP Morgan, 27.90%) | Hold |
| Average | 31.50 (49.22%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 21.21 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Cantor Fitzgerald | 07 Oct 2025 | 36.00 (70.54%) | Buy | 20.39 |
| JP Morgan | 18 Sep 2025 | 27.00 (27.90%) | Hold | 22.03 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Aug 2025 | Announcement | Surgery Partners, Inc. Announces Second Quarter 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |